Literature DB >> 12918101

Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells.

Ming-Yi Li1, Hua Deng, Jia-Ming Zhao, Dong Dai, Xiao-Yu Tan.   

Abstract

AIM: To investigate the characteristics of PPAR gamma ligands induced apoptosis in liver cancer cells.
METHODS: The effects of ligands for each of the PPAR gamma ligands on DNA synthesis and cell viability were examined in BEL-7402 liver cancer cells. Apoptosis was characterized by Hochest33258 staining, DNA fragmentation, TUNEL and ELISA, and cell cycle kinetics by FACS. Modulation of apoptosis related caspases expression by PPAR gamma ligands was examined by Western blot.
RESULTS: PPARgamma ligands, 15-deoxy-(12), (14)-prostaglandin J2 (15d-PGJ2) and troglitazone (TGZ), suppressed DNA synthesis of BEL-7402 cells. Both 15d-PGJ2 and TGZ induced BEL-7402 cell death in a dose dependent manner, which was associated with an increase in fragmented DNA and TUNEL-positive cells. At concentrations of 10 and 30 microM, 15d-PGJ(2) or troglitazone increased the proportion of cells with G(0)/G(1) phase DNA content and decreased those with S phase DNA content. There was no significant change in the proportion of cells with G(2)/M DNA content. The activities of Caspases-3, -6, -7 and -9 were increased by 15d-PGJ2 and TGZ treatment, while the activity of Caspase 8 had not significantly changed.
CONCLUSION: The present results suggest the potential usefulness of PPAR gamma ligands for chemoprevention and treatment of liver cancers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12918101      PMCID: PMC4611524          DOI: 10.3748/wjg.v9.i8.1683

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  65 in total

1.  Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes.

Authors:  U Kintscher; S Goetze; S Wakino; S Kim; S Nagpal; R A Chandraratna; K Graf; E Fleck; W A Hsueh; R E Law
Journal:  Eur J Pharmacol       Date:  2000-08-11       Impact factor: 4.432

2.  Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa.

Authors:  A Mansén; H Guardiola-Diaz; J Rafter; C Branting; J A Gustafsson
Journal:  Biochem Biophys Res Commun       Date:  1996-05-24       Impact factor: 3.575

3.  15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway.

Authors:  Sarah G Harris; Roger S Smith; Richard P Phipps
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

4.  Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids.

Authors:  H Asou; W Verbeek; E Williamson; E Elstner; T Kubota; N Kamada; H P Koeffler
Journal:  Int J Oncol       Date:  1999-11       Impact factor: 5.650

5.  Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells.

Authors:  N Takahashi; T Okumura; W Motomura; Y Fujimoto; I Kawabata; Y Kohgo
Journal:  FEBS Lett       Date:  1999-07-16       Impact factor: 4.124

6.  Synergism between heparin and adriamycin on cell proliferation and apoptosis in human nasopharyngeal carcinoma CNE2 cells.

Authors:  Hong-Ling Li; Xian-Da Ren; Hai-Wei Zhang; Chun-Ling Ye; Jun-Hua Lv; Pei-E Zheng
Journal:  Acta Pharmacol Sin       Date:  2002-02       Impact factor: 6.150

7.  Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity.

Authors:  N Yamakawa-Karakida; K Sugita; T Inukai; K Goi; M Nakamura; K Uno; H Sato; K Kagami; N Barker; S Nakazawa
Journal:  Cell Death Differ       Date:  2002-05       Impact factor: 15.828

8.  Androgen modulation of adhesion and antiadhesion molecules in PC-3 prostate cancer cells expressing androgen receptor.

Authors:  Andreas Evangelou; Michelle Letarte; Alexander Marks; Theodore J Brown
Journal:  Endocrinology       Date:  2002-10       Impact factor: 4.736

9.  Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer.

Authors:  Yukio Terashita; Hidefumi Sasaki; Nobuhiro Haruki; Tadashi Nishiwaki; Hideyuki Ishiguro; Yasuyuki Shibata; Junzo Kudo; Shigeru Konishi; Joji Kato; Hiroshi Koyama; Masahiro Kimura; Atsushi Sato; Noriyuki Shinoda; Yoshiyuki Kuwabara; Yoshitaka Fujii
Journal:  Jpn J Clin Oncol       Date:  2002-07       Impact factor: 3.019

10.  Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, modulates the E-cadherin/beta-catenin system in a human pancreatic cancer cell line, BxPC-3.

Authors:  Tetsuo Ohta; Ayman Elnemr; Miyuki Yamamoto; Itasu Ninomiya; Sachio Fushida; Gen-Ichi Nishimura; Takashi Fujimura; Hirohisa Kitagawa; Masato Kayahara; Koichi Shimizu; Shuangqin Yi; Koichi Miwa
Journal:  Int J Oncol       Date:  2002-07       Impact factor: 5.650

View more
  14 in total

1.  Effect of ligand troglitazone on peroxisome proliferator-activated receptor gamma expression and cellular growth in human colon cancer cells.

Authors:  Mei Ming; Jie-Ping Yu; Xiang-Zhi Meng; Yan-Hong Zhou; Hong-Gang Yu; He-Sheng Luo
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

2.  Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo.

Authors:  Jai Prakash; Ruchi Bansal; Eduard Post; Alie de Jager-Krikken; Marjolijn N Lub-de Hooge; Klaas Poelstra
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

3.  PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer.

Authors:  A Belfiore; M Genua; R Malaguarnera
Journal:  PPAR Res       Date:  2009-07-07       Impact factor: 4.964

4.  Peroxisome proliferator activated receptor-gamma in pathogenesis of experimental fatty liver disease.

Authors:  Cai-Yan Zhao; Ling-Ling Jiang; Li Li; Zhuo-Jun Deng; Bao-Li Liang; Jian-Mei Li
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

5.  Protective role of metallothionein (I/II) against pathological damage and apoptosis induced by dimethylarsinic acid.

Authors:  Guang Jia; Yi-Qun Gu; Kung-Tung Chen; You-Yong Lu; Lei Yan; Jian-Ling Wang; Ya-Ping Su; J C Gaston Wu
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

6.  Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver.

Authors:  Alexandra Rogue; Catherine Spire; Manuel Brun; Nancy Claude; André Guillouzo
Journal:  PPAR Res       Date:  2010-10-19       Impact factor: 4.964

7.  The insulin receptor: a new target for cancer therapy.

Authors:  Roberta Malaguarnera; Antonino Belfiore
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-06       Impact factor: 5.555

8.  Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell lines.

Authors:  Sharon E Campbell; William L Stone; Steven Lee; Sarah Whaley; Hongsong Yang; Min Qui; Paige Goforth; Devin Sherman; Derek McHaffie; Koyamangalath Krishnan
Journal:  BMC Cancer       Date:  2006-01-17       Impact factor: 4.430

9.  Polyunsaturated fatty acids augment tumoricidal action of 5-fluorouracil on gastric cancer cells by their action on vascular endothelial growth factor, tumor necrosis factor-α and lipid metabolism related factors.

Authors:  Haining Yu; Yan Liu; Wensheng Pan; Shengrong Shen; Undurti N Das
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

10.  The Role of PPARgamma in Hepatocellular Carcinoma.

Authors:  Ivan Borbath; Yves Horsmans
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.